Exploring therapeutic index of desmopressin for treating primary nocturnal enuresis in children
MA Jun,JIN Xing-ming,ZHANG Yi-wen,WU Hong,JIANG Fan
DOI: https://doi.org/10.3969/j.issn.1673-5501.2007.05.006
2007-01-01
Abstract:Objective Studying the clinical efficacy and therapeutic index of desmopressin for treating primary nocturnal enuresis in Chinese children.Methods The objects of the study were 160 children who were diagnosed as primary nocturnal enuresis(PNE) in department of developmental and behavioral pediatrics of Shanghai children's medical center from April 2003 to August 2006, included 82 boys and 78 girls; The age range was 5 to 16, mean age was (8.26±2.84) years old. PNE diagnosis strictly followed International Classification of Diseases, the 10th edition (ICD-10). Based on Chinese enuretic children's characteristics, the enuresis questionnaire was formed, including general conditions, clinical manifestations, clinical history, birth history, developmental and behavioral history, family history, psychological and social environments, outcomes of psychological tests(including Achenbach children behavioral checklist, Wechsler intelligence scale for children-Revised, Wechsler preschool and primary scale of intelligence), day-time functional bladder capacity, outcomes of laboratory tests(such as urine routine, nocturnal urine specific gravity, x-ray graph of lumbar and sacral vertebrae, ultrasonic graph of urinary system etc), diagnosis, treatment procedure. The variables involved in the questionnaire were 43. All patients were treated with oral desmopressin. Before treatment, the blood pressure was tested. If it was abnormal, desmopressin should not be applied. Desmopressin was taken under the condition of stopping drinking water or any waterful food (like milk, watermelon and so on) after 5 pm. Oral desmopressin was taken with 10-20 mL water 30 minutes before bed time. The short-term and long-term efficacy, changes in the period of treatment were observed. Logistic multi-factor analysis was applied to find out the therapeutic index that improved clinical efficacy of desmopressin. Results The short-term and long-term cure rates were 40.6% and 28.1%, respectively; The relapse rate was 57.5% 3 months after stopping desmopressin use. During the first month of treatment, the average frequency of enuretic onsets decreased dramatically from 6.38±1.82 times per week to 3.16±0.95 times per week whereas during the second, third and fourth month of treatment, the average frequency of enuretic onsets decreased mildly from 3.16±0.95 times per week to 2.54±0.69 times per week. Among 160 enuretic children, 85 children never got up to urinate by themselves before treatment, however after treatment there were 23 children who developed the ability to get up to urinate by themselves when the bladder was full during sleep. During the first month of treatment period, the median of enuretic occurrence time postponed apparently from 2 to 3am to 4 to 5am. Logistic regression analysis showed the risk factors that decrease efficacy of desmopressin were more than 7 times of bed-wetting onsets(RR=3.15,95%CI:2.84-4.64), less than 5ml/kg of the functional bladder capacity(RR=2.92,95%CI:1.86-3.93), nocturnally first bed-wetting onset after 4 am(RR=1.65,95%CI:1.16-2.55).Conclusions The short-term efficacy of desmopressin was rapid and good but the relapse rate was high, so the long-term efficacy of desmopressin was decreased. The clinical efficacy of desmopressin would be improved dramatically if selecting patients with bigger functional bladder capacity, fewer bed-wetting onsets, nocturnally first bed-wetting onset after 4 am.